{
  "ticker": "NVO",
  "name": "Novo Nordisk A/S",
  "price": 50.18,
  "market_cap": 222973804544,
  "revenue_ttm": 49618432223.37515,
  "net_income_ttm": 16314970285.822092,
  "ocf_ttm": 19461057132.974876,
  "capex_ttm": 9878627802.408579,
  "sbc_ttm": 0.0,
  "buyback_ttm": 1395937490.173883,
  "total_debt": 15912649750.023582,
  "cash_and_equivalents": 5122629940.571645,
  "book_value_ttm": 26710687670.974438,
  "shares_outstanding": 3368607341,
  "beta": 1.2,
  "roe": 71.47,
  "analyst_growth_estimate": 5.1,
  "forward_eps": 3.4670882,
  "dividend_yield": 344.0,
  "sector_type": "BioTech",
  "currency_code": "USD",
  "last_updated": "2025-12-14T18:24:47Z"
}